XML 25 R10.htm IDEA: XBRL DOCUMENT
v3.7.0.1

Net (Loss) Income Per Share | 12 Months Ended
--- | ---
Dec. 31, 2016
Earnings Per Share [Abstract] |
Net (Loss) Income Per Share | 3. NET (LOSS) INCOME PER SHARE Basic net (loss) income per share has been computed by dividing the net (loss) income by the weighted-average number of common shares outstanding during the period, without consideration for common share equivalents. Diluted net (loss) income per share has been computed by dividing the net (loss) income by the sum of the weighted-average number of common shares and common share equivalents outstanding during the period, to the extent that such common share equivalents are dilutive. For the years ended December 31, 2016 and 2015, all common share equivalents have been excluded from the calculation of diluted net loss per share, as their effect would be antidilutive. For the year ended December 31, 2014, certain common share equivalents have been included in diluted net income per share, as their effect is dilutive. For the year ended December 31, 2014, common share equivalents include: (i) options and warrants to purchase common stock; (ii) options and warrants to purchase convertible preferred stock prior to their conversion into options and warrants to purchase common stock upon the IPO; and (iii) convertible preferred stock and the subordinated convertible note prior to their conversion into common stock upon the IPO. Common share equivalents for convertible preferred stock and the subordinated convertible note are determined using the if-converted method. Common share equivalents for options and warrants are determined using the treasury-stock method. The following tables set forth the computation of the Company’s basic and diluted net (loss) income per share (in thousands, except shares and per share data):
|  | Year Ended December 31, |
|  | 2016 |  |  | 2015 |  |  | 2014 |
Numerator: |  |  |  |  |  |  |  |  |  |  |  |
Net (loss) income attributable to CareDx, Inc. used to compute basic net loss per share |  | $ | (39,469 | ) |  | $ | (13,707 | ) |  | $ | 781 |
Add: interest expense related to subordinated convertible note |  |  | — |  |  |  | — |  |  |  | 364 |
Less: gain on change in fair value of derivative related to subordinated convertible note |  |  | — |  |  |  | — |  |  |  | (118 | )
Less: gain on extinguishment of derivative related to subordinated convertible note |  |  | — |  |  |  | — |  |  |  | (120 | )
Net (loss) income attributable to CareDx, Inc. used to compute diluted net loss per share |  | $ | (39,469 | ) |  | $ | (13,707 | ) |  | $ | 907 |
Denominator: |  |  |  |  |  |  |  |  |  |  |  |
Weighted-average shares used to compute basic net (loss) income per share attributable to CareDx, Inc. |  |  | 16,496,911 |  |  |  | 11,860,885 |  |  |  | 5,815,928 |
Effect of potentially dilutive securities: |  |  |  |  |  |  |  |  |  |  |  |
Convertible preferred stock |  |  | — |  |  |  | — |  |  |  | — |
Convertible preferred stock |  |  | — |  |  |  | — |  |  |  | 2,972,051 |
Subordinated convertible note |  |  | — |  |  |  | — |  |  |  | 134,341 |
Employee stock options |  |  | — |  |  |  | — |  |  |  | 360,681 |
Weighted-average shares used to compute diluted net (loss) income per share attributable to CareDx, Inc. |  |  | 16,496,911 |  |  |  | 11,860,885 |  |  |  | 9,283,001 |
Net (loss) income per share attributable to CareDx, Inc.: |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | (2.39 | ) |  | $ | (1.16 | ) |  | $ | 0.13 |
Diluted |  | $ | (2.39 | ) |  | $ | (1.16 | ) |  | $ | 0.10 |
The following potentially dilutive securities have been excluded from diluted net (loss) income per share, because their effect would be antidilutive:
|  | Year Ended December 31, |
|  | 2016 |  |  | 2015 |  |  | 2014 |
Shares of common stock subject to outstanding options |  |  | 1,757,309 |  |  |  | 1,577,317 |  |  |  | 539,645 |
Shares of common stock subject to outstanding common stock warrants |  |  | 3,259,926 |  |  |  | 301,069 |  |  |  | 213,677 |
Restricted stock units |  |  | 306,245 |  |  |  | 106,200 |  |  |  | — |
Total common stock equivalents |  |  | 5,323,480 |  |  |  | 1,984,586 |  |  |  | 753,322 |
The Company issued 4,630,145 shares of preferred stock pursuant to the Private Placement and Subsequent Financing, which were completed on April 14, 2016 and June 15, 2016, respectively. All of the preferred stock was converted to common stock upon receipt of the Requisite Stockholder Approval on June 16, 2016. As of December 31, 2016, there was no preferred stock outstanding. On September 26, 2016, the Company completed the Public Offering pursuant to which the Company issued and sold an aggregate of 2,250,000 shares of common stock.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=64863997&loc=d3e1278-109256 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=64863997&loc=d3e1252-109256 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 55 -Paragraph 52 -URI http://asc.fasb.org/extlink&oid=65016374&loc=d3e4984-109258 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.21) -URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration